Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4086-4089, August 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomassen, M. J.
Right arrow Articles by Ahmad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomassen, M. J.
Right arrow Articles by Ahmad, M.

Differential Effect of Recombinant Granulocyte Macrophage Colony-stimulating Factor on Human Monocytes and Alveolar Macrophages1

Mary Jane Thomassen2, Barbara P. Barna, Denise Rankin, Herbert P. Wiedemann and Muzaffar Ahmad

Departments of Pulmonary Disease [M. J. T., H. P. W., M. A.], and Immunopathology [B. P. B.] and the Research Institute [M. J. T., D. R.], The Cleveland Clinic Foundation, Cleveland, Ohio 44195-5038

The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), a pluripotent cytokine, on tumoricidal activity of alveolar macrophages and monocytes from nonsmoking normal volunteers was compared using [3H]thymidine-labeled human tumor cells (SK-MEL-28, melanoma) as targets. A dose-response study (500–5000 units/ml) of recombinant GM-CSF indicated dramatic differences between cytotoxicity of alveolar macrophages and blood monocytes. Macrophages exhibited significant (P < 0.01) tumoricidal activity at all GM-CSF doses tested. In contrast, monocytes showed no significant tumoricidal activity at 500 units/ml and significantly (P < 0.01) less activity than alveolar macrophages at doses of 1000–5000 units/ml. Maximal activity in alveolar macrophages occurred 72–96 h after exposure to 1000–5000 units/ml GM-CSF. Tumoricidal activity may be related to the state of maturation, because monocytes matured in vitro for 7 days displayed enhanced tumoricidal activity after GM-CSF exposure. Tumor necrosis factor {alpha} and interleukin 1ß were measured in supernatant fluids of 24-h GM-CSF-treated cells. No significant increase in either cytokine was detected after GM-CSF treatment of alveolar macrophages. Monocyte interleukin 1ß secretion was not enhanced by GM-CSF; however, tumor necrosis factor {alpha} secretion was enhanced in some donors (three of five). Superoxide anion production of alveolar macrophages was not enhanced by GM-CSF. These data suggest that alveolar macrophage tumoricidal activity is induced by GM-CSF and is not dependent on oxidative metabolism or secreted forms of interleukin 1ß or tumor necrosis factor {alpha}.

1 This work was supported by NIH Grant HL 36078, a grant from the Cuyahoga County Unit of the American Cancer Society, and the DeBartolo Scholar Award.

2 To whom requests for reprints should be addressed.

Received 12/29/88. Revised 2/27/89. Accepted 4/25/89.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. M. Rotoli, V. Dall'Asta, A. Barilli, R. D'Ippolito, A. Tipa, D. Olivieri, G. C. Gazzola, and O. Bussolati
Alveolar Macrophages from Normal Subjects Lack the NOS-Related System y+ for Arginine Transport
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. E. Spitler, M. L. Grossbard, M. S. Ernstoff, G. Silver, M. Jacobs, F. A. Hayes, and S. J. Soong
Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor
J. Clin. Oncol., April 1, 2000; 18(8): 1614 - 1621.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.L. Scott, D.A. Hughes, D. Cary, N.A. Nicola, C.G. Begley, and L. Robb
Functional Analysis of Mature Hematopoietic Cells From Mice Lacking the beta c Chain of the Granulocyte-Macrophage Colony-Stimulating Factor Receptor
Blood, December 1, 1998; 92(11): 4119 - 4127.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. F. Seymour, C. G. Begley, U. Dirksen, J. J. Presneill, N. A. Nicola, P. E. Moore, O. D. Schoch, P. vanAsperen, B. Roth, S. Burdach, et al.
Attenuated Hematopoietic Response to Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Acquired Pulmonary Alveolar Proteinosis
Blood, October 15, 1998; 92(8): 2657 - 2667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. C. BALDWIN, D. P. TASHKIN, D. M. BUCKLEY, A. N. PARK, S. M. DUBINETT, and M. D. ROTH
Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production
Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1606 - 1613.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.